~~<i id='3A8E43C179'><strike id='3A8E43C179'><tt id='3A8E43C179'><pre id='3A8E43C179'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：leisure time 2025-10-01 02:16:07 - browse：16418

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： What Congress can do to address the rural doctor shortage

focus

leisure time

focus

explore

knowledge

hotspot

AlastairGrant/APLONDON—AstraZenecasaidFridayanexperimentaldrugtampeddowntheprogressionofacertaintype

WSS

Microbiome research is starting to find links to chronic diseases

Key Senate committee drafts bipartisan bill to stem drug shortages

Lasker Awards 2023: Winners in biomedical research

Senate HELP committee spars over health care workforce policies

Biotech lab space demand falls sharply

How AI helped researchers track recovery from depression

hotspot

knowledge

focus

As demand for Covid shots wanes, Moderna seeks its next success

Intarcia’s device

Medicare details structure of new drug price negotiation program

Thermo Fisher plant for manufacturing gene therapies to expand

Trump demands the U.S. pay no more for drugs than other countries … again

Medical student insurance fails on mental health care coverage

Walensky prepares to leave CDC — and Congress — behind

It's been 20 years since Dolly the sheep. Where's my clone?

What does generative AI mean for health care? We asked experts

Dogs on Prozac: What pet anti

leisure time

Cholera vaccine supply gets boost as demand surges globally

After traumatic brain injury, life support decisions can use more time

Microbiome research is starting to find links to chronic diseases

MassMutual is introducing free genetic testing for members

Diversity in clinical trials starts with building trust, experts say

Hearing on Medicare drug price negotiation gets unusually heated

focus

explore

knowledge

hotspot